BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Astex Technology Limited

Below is an extended Astex Technology Limited research listing. Click here to return to the Astex Technology Limited main Biocorporate entry.

Recent Publications by Astex Technology Limited:

Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
The cytochromes P450 (P450s) are a family of heme-containing monooxygenase...
13th June, 2006
Astex Technology, Cambridge, United Kingdom. Proteins. 2005 Mar 1;58(4):836-44.
DOI Direct Link
Structural biology and drug discovery.
It has long been recognized that knowledge of the 3D structures of...
25th May, 2006
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge CB4 Drug Discov Today. 2005 Jul 1;10(13):895-907.
DOI Direct Link
Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery.
Since the discovery that activating mutations of the Ras GTPase were...
25th May, 2006
Astex Technology Ltd, 436 Cambridge Science Park, Milton Rd, Cambridge CB4 Curr Opin Pharmacol. 2005 Aug;5(4):350-6.
DOI Direct Link
Fragment-based lead discovery: leads by design.
Fragment-based lead discovery (also referred to as needles, shapes,...
20th April, 2006
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge CB4 Drug Discov Today. 2005 Jul 15;10(14):987-92.
DOI Direct Link
The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3).
Extensive SAR studies on the unselective BRS3 agonist,...
8th November, 2005
Astex J Pept Sci. 2005 Mar;11(3):136-41.
DOI Direct Link
The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
This article describes the application of a high-throughput X-ray...
23rd June, 2005
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 Chembiochem. 2005 Mar;6(3):506-12.
DOI Direct Link
Virtual screening using protein-ligand docking: avoiding artificial enrichment.
This study addresses a number of topical issues around the use of...
22nd March, 2005
Astex Technology Ltd., 436 Cambridge Science Park, Milton Road, Cambridge J Chem Inf Comput Sci. 2004 May-Jun;44(3):793-806.
DOI Direct Link
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.
We describe the structure-guided optimization of the molecular fragments...
5th March, 2005
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 J Med Chem. 2005 Jan 27;48(2):414-26.
DOI Direct Link
Fragment-based lead discovery using X-ray crystallography.
Fragment screening offers an alternative to traditional screening for...
5th March, 2005
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 J Med Chem. 2005 Jan 27;48(2):403-13.
DOI Direct Link
High-throughput protein crystallography and drug discovery.
Single crystal X-ray diffraction is the technique of choice for studying...
23rd February, 2005
Astex Technology Ltd., 436 Science Park, Milton Road, Cambridge, UK. Chem Soc Rev. 2004 Oct 20;33(8):558-65. Epub 2004 Sep 20.
DOI Direct Link
Apo and inhibitor complex structures of BACE (beta-secretase).
Human BACE, also known as beta-secretase, shows promise as a potential...
16th November, 2004
Astex Technology, 436 Cambridge Science Park, Milton Road, CB4 0QA, UK. J Mol Biol. 2004 Oct 15;343(2):407-16.
DOI Direct Link
Structure-guided fragment screening for lead discovery.
Fragment-based ligand screening can be a highly effective strategy for...
29th September, 2004
Astex Technology Ltd, 436 Cambridge Science Park, Milton Road, Cambridge, Curr Opin Drug Discov Devel. 2004 Jul;7(4):404-10.
Fragment-based lead discovery.
Fragment-based ligand screening can be a highly effective strategy for...
1st September, 2004
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge CB4 Nat Rev Drug Discov. 2004 Aug;3(8):660-72.
DOI Direct Link
Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.
Cytochromes P450 (P450s) metabolize a wide range of endogenous compounds...
11th August, 2004
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 Science. 2004 Jul 30;305(5684):683-6. Epub 2004 Jul 15.
DOI Direct Link
New lead generation strategies for protein kinase inhibitors - fragment based screening approaches.
The protein kinase superfamily represents both an enormous opportunity and...
15th May, 2004
Astex Technology, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 Mini Rev Med Chem. 2004 Mar;4(3):301-11.

«Astex Technology Limited

This page contained an extended Astex Technology Limited research listing. Click here to return to the Astex Technology Limited main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.